跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTONEL 5mg risedronate sodium 5mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ACTONEL 5mg risedronate sodium 5mg tablet blister pack
Approved
STANDARD
ACTONEL 5mg risedronate sodium 5mg tablet blister pack
Theramex Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ef28a1a96b4226e3
Company
Theramex Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ef28a1a96b4226e3
Product Name
ACTONEL 5mg risedronate sodium 5mg tablet blister pack
Artg Id
74135
Artg Name
ACTONEL 5mg risedronate sodium 5mg tablet blister pack
Sponsor
Theramex Australia Pty Ltd
Company Detail Path
/organization/theramex-australia-pty-ltd
Artg Date
2000-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/dbe6fecfa6682d2807c2937e867ab98a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/97049d058fdd8caffc4c4939a3477cf7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ef28a1a96b4226e3
Type
Standard
Back to TGA Approvals